Oregon · 2025 Regular Session · Bill
HB 2103: Relating to xylazine.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 2103 is a bill introduced in the Oregon House on January 13, 2025. According to its official title, it concerns: Relating to xylazine. Primary sponsor: Virgle Osborne (Republican). Most recent recorded action (June 28, 2025): In committee upon adjournment.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Virgle Osborne | Primary sponsor | Republican | House | 2 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- In committee upon adjournment.
- Referred to Behavioral Health and Health Care.
- First reading. Referred to Speaker's desk.